BMS-813160
CAS: 1286279-29-5
Ref. TM-T4584
| 1mg | 62.00 € | ||
| 5mg | 135.00 € | ||
| 10mg | 185.00 € | ||
| 25mg | 337.00 € | ||
| 50mg | 560.00 € | ||
| 100mg | 799.00 € | ||
| 500mg | 1,613.00 € | ||
| 1mL*10mM (DMSO) | 144.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Product Information
Name:
BMS-813160
Synonyms:
- BMS813160
Description:
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
484.64
Formula:
C25H40N8O2
Purity:
99.66% - 99.78%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T4584 BMS-813160
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
